Resources Contact Us Home
Recombinant P. falciparum merozoite protein-142 vaccine

Image Number 5 for United States Patent #7306806.

In this application is the expression and purification of a recombinant Plasmodium falciparum (3D7) MSP-1.sub.42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant MSP-1.sub.42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

  Recently Added Patents
Hybrid coatings and associated methods of application
System and method for combining different tablets into a pouch
Perfume bottle
Systems and methods for synchronizing and controlling multiple image sensors
Mask and method for forming the mask
Method and apparatus for the prevention of a service degradation attack
Method for the synthesis of an array of metal nanowire capable of supporting localized plasmon resonances and photonic device comprising said array
  Randomly Featured Patents
Broadcast reception device and contract management device using common master key in conditional access broadcast system
OP-3- induced morphongenesis
Methods and apparatus for rotary machinery inspection
Method and system for forming source regions in memory devices
System and method for maintaining a plurality of summary levels in a single table
Process for obtaining acyloins, pyruvate decarboxylases suitable therefor and their production and DNA sequence of the PDC gene coding them
Device for reducing fibrous products
Antimicrobial quaternary ammonium group-containing polymers, compositions thereof, and monomers used to produce said polymers
Optical disk and optical disk recording and reproducing apparatus
Optical path for a scanning system